	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S60-PMC2996405	PMC2996405	11/2010	S60-PMC2996405	['OUR FINDINGS SUGGEST a molecular LINK among latitude, schizophrenia and Vitamin D.\n\nresults\na set of Snps showing high levels of latitude-DEPENDENT population differentiation was selected by using a two-step approach.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 138)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('SO_0000694', 'SNP', 101, 'SNPs')]
S109-PMC2996405	PMC2996405	11/2010	S109-PMC2996405	['we checked WHETHER OR NOT in these 9 Genes belonged Snps, selected by our procedure, that were PREVIOUSLY studied in RELATIONSHIP to either schizophrenia or Vitamin D RELATED phenotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('SO_0000704', 'gene', 37, 'genes'), ('SO_0000694', 'SNP', 52, 'SNPs'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S65-PMC3427192	PMC3427192	4/2012	S65-PMC3427192	['Haplotype analysis of the vdr polymorphisms SHOWED a significant ASSOCIATION with asthmavollmert90200432munich, germany/ germansnps in the vdr and Integrin Β7None of the Snps were ASSOCIATED with asthmawjst912005951munich, germany/ germany and sweden13 Snps in the vdrin unaffected siblings, Allele in the 5′ region was undertransmitted while two other Alleles in the 3′ terminal region were overtransmittedwjst922006947munich, germany/ germany and swedenserum levels of Vitamin D and genotyping of dna Single Base variantsat least one positive Snp with a transmission disequilibrium of for asthma or total Ige and Vitamin D was FOUND in several Genes\nONLY a HANDFUL OF STUDIES have evaluated the LINK between asthma and polymorphisms in other Genes INVOLVED in Vitamin d synthesis, bioavailability and Metabolism.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 629), ('INCOMPLETE_EVIDENCE', 652), ('INCOMPLETE_EVIDENCE', 659), ('SUPERFICIAL_RELATIONSHIP', 697), ('SUPERFICIAL_RELATIONSHIP', 750)]	8	[('SO_0001024', 'haplotype', 0, 'Haplotype'), ('PR_000009070', 'integrator complex subunit 3', 147, 'integrin β7None'), ('SO_0000694', 'SNP', 170, 'SNPs'), ('SO_0000694', 'SNP', 253, 'SNPs'), ('SO_0001023', 'allele', 292, 'allele'), ('SO_0001023', 'allele', 353, 'alleles'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D'), ('SO_0000984', 'single', 503, 'single base'), ('SO_0000694', 'SNP', 545, 'SNP'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 607, 'IgE'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('SO_0000704', 'gene', 646, 'genes'), ('SO_0000704', 'gene', 744, 'genes'), ('CHEBI_33229', 'vitamin (role)', 762, 'vitamin'), ('GO_0008152', 'metabolic process', 803, 'metabolism')]
S3-PMC3515553	PMC3515553	12/2012	S3-PMC3515553	['we then examined the ASSOCIATION of Snps in maternal Genes Fut2 (rs492602) and tcn2 (rs1801198, rs9606756) that are RELATED to Plasma Vitamin B-12, with offspring iq.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('SO_0000694', 'SNP', 36, 'SNPs'), ('SO_0000704', 'gene', 53, 'genes'), ('PR_000007719', 'frizzled-2', 59, 'FUT2'), ('UBERON_0001969', 'blood plasma', 127, 'plasma'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 134, 'vitamin B-12')]
S6-PMC3515553	PMC3515553	12/2012	S6-PMC3515553	['the expected EFFECT of maternal Vitamin B-12 on offspring iq, GIVEN the RELATIONSHIPS between Snps and Vitamin B-12, and Snps and iq was consistent with the OBSERVATIONAL result.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 62), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 157)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 32, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 42, '12'), ('SO_0000694', 'SNP', 94, 'SNPs'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 103, 'vitamin B-12'), ('SO_0000694', 'SNP', 121, 'SNPs')]
S21-PMC3515553	PMC3515553	12/2012	S21-PMC3515553	['the AIM of THIS STUDY was TO EXAMINE the ASSOCIATION of maternal dietary Intake of Vitamin B-12 and also of Snps in Fut2 and tcn2 with offspring iq assessed at age 8 in a population of european origin.figure 1shows the framework for the HYPOTHESIS that we have EXAMINED HERE concerning the LINKS between maternal Vitamin B-12 during Pregnancy with offspring iq.10.1371/journal.pone.0051084.g001\n\ncaption (fig): figure 1\ndiagram showing the framework of the mendelian randomization approach used in this study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 237), ('QUESTION_ANSWERED_BY_THIS_WORK', 261), ('QUESTION_ANSWERED_BY_THIS_WORK', 270), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 83, 'vitamin B-12'), ('SO_0000694', 'SNP', 108, 'SNPs'), ('PR_000007719', 'frizzled-2', 116, 'FUT2'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin B'), ('GO_0007565', 'female pregnancy', 333, 'pregnancy')]
S60-PMC3515553	PMC3515553	12/2012	S60-PMC3515553	['Haplotypes consisting of both tcn2 Snps were evaluated AS POTENTIAL instrumental variables that MAY EXPLAIN better than genotypes part of the variation in circulating Vitamin B-12.']	[('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 100)]	4	[('SO_0001024', 'haplotype', 0, 'Haplotypes'), ('SO_0000694', 'SNP', 35, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 167, 'vitamin B-12')]
S93-PMC3515553	PMC3515553	12/2012	S93-PMC3515553	['Vitamin B-12 status RELATED Snps, maternal dietary intake of Vitamin B-12 and Cord Blood Vitamin B-12\nneither of the maternal Snps was associated with maternal dietary Intake of Vitamin B-12 during Pregnancy in a linear model, ALTHOUGH tcn2 rs1801198 heterozygotes showed higher Vitamin B-12 intake than either homozygote group (p\u200a=\u200a0.02).']	[('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B-12'), ('SO_0000694', 'SNP', 28, 'SNPs'), ('PR_000017269', 'ventral anterior homeobox 2', 61, 'Vitamin B-12'), ('UBERON_0000948', 'heart', 78, 'Cord'), ('UBERON_0000178', 'blood', 83, 'Blood'), ('PR_000017269', 'ventral anterior homeobox 2', 89, 'Vitamin B-12'), ('SO_0000694', 'SNP', 126, 'SNPs'), ('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 178, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 279, 'vitamin B-12')]
S94-PMC3515553	PMC3515553	12/2012	S94-PMC3515553	['all three maternal Snps SHOWED a SIMILAR magnitude of EFFECT on Cord Blood Vitamin B-12 concentration, but statistical EVIDENCE for the EFFECT of the Fut2 Snp and tcn2 rs9606756 was absent in this SMALL sample (table 3).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 197)]	6	[('SO_0000694', 'SNP', 19, 'SNPs'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 75, 'vitamin B-12'), ('PR_000007719', 'frizzled-2', 150, 'FUT2'), ('SO_0000694', 'SNP', 155, 'SNP')]
S99-PMC3515553	PMC3515553	12/2012	S99-PMC3515553	['offspring Haplotypes were not associated with Cord Blood Vitamin B-12 (data not shown).10.1371/journal.pone.0051084.t003\n\ncaption (table-wrap): table 3\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with maternal dietary intake at 32 weeks Pregnant and Vitamin B-12 Cord Blood concentration.Snpgenotypenamedian (iqr) of maternal Vitaminb-12 dietary intake (µg/day)nmedian (iqr) of Vitamin B-12 Cord Blood (pmol/l) Fut2 rs492602tt16424.2 (3.0, 6.1)62291 (183, 397)tc31874.2 (3.0, 6.1)128300 (196, 424)cc16484.3 (3.0, 6.2)50294 (214, 534)ratio of geometric means perc Allele (95% ci)64771.00 (0.98, 1.02)2401.08 (0.97, 1.19)p-valuea0.82/0.960.15/0.31 tcn2 rs1801198gg12764.1 (3.0, 5.9)41276 (173, 369)cg32214.3 (3.2, 6.2)125279 (196, 417)cc20024.1 (3.0, 6.1)68318 (226, 436)ratio of geometric meansper c Allele (95% ci)64991.01 (0.99, 1.03)2341.13 (1.02–1.25)p-valuea0.44/0.020.02/0.07 tcn2 rs9606756aa54834.3 (3.1, 6.2)193288 (205, 397)ag16504.3 (3.0, 6.1)58298 (206, 484)gg1204.0 (2.9, 6.1)2238 (82, 394)ratio of geometric meansper G Allele (95% ci)72530.99 (0.96, 1.01)2531.03 (0.89, 1.18)p-valuea0.23/0.460.73/0.31\nn reflects the number of mothers with genotype and dietary Intake or offspring Cord Blood Vitamin B-12 data, regardless of whether there was offspring iq data available for them as well.']	[('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 193)]	2	[('SO_0001024', 'haplotype', 10, 'haplotypes'), ('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('SO_0000694', 'SNP', 188, 'SNPs'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 204, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 204, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 269, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin B'), ('UBERON_0002240', 'spinal cord', 295, 'cord'), ('UBERON_0000178', 'blood', 300, 'blood'), ('SO_0001744', 'UPD', 320, 'SNPgenotypeNamedian'), ('CHEBI_27300', 'vitamin D', 358, 'vitaminB'), ('PR_000017269', 'ventral anterior homeobox 2', 358, 'vitaminB-12'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin B'), ('UBERON_0002240', 'spinal cord', 423, 'cord'), ('UBERON_0000178', 'blood', 428, 'blood'), ('PR_000007719', 'frizzled-2', 443, 'FUT2'), ('SO_0001023', 'allele', 595, 'allele'), ('SO_0001023', 'allele', 831, 'allele'), ('SO_0001434', 'cassette_pseudogene', 1061, 'G'), ('SO_0001023', 'allele', 1063, 'allele'), ('GO_0007631', 'feeding behavior', 1205, 'intake'), ('UBERON_0002240', 'spinal cord', 1225, 'cord'), ('UBERON_0000178', 'blood', 1230, 'blood'), ('CHEBI_27300', 'vitamin D', 1236, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 1236, 'vitamin B-12')]
S110-PMC3515553	PMC3515553	12/2012	S110-PMC3515553	['encoding aminoacids valine (v) at locus rs9606756 and arginine (r) at locus rs1801198) was ASSOCIATED with a considerable increase in iq scores (mean difference in iq per gg copy 4.2; 95%ci 1.2, 7.2).10.1371/journal.pone.0051084.t005\n\ncaption (table-wrap): table 5\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with offspring iq at age 8.Snpgenotypeniq mean (sd) Fut2 rs492602tt1009103.3 (16.8)tc1940104.2 (16.1)cc1012105.0 (16.7)mean difference in child iq per callelea(95% ci)39610.86 (0.14, 1.58)p-value0.02 tcn2 rs1801198gg784103.9 (16.6)cg1978104.1 (16.0)cc1208104.6 (17.0)mean difference in child iq per callelea(95% ci)39700.35 (−0.38, 1.08)p-value0.35 tcn2 rs9606756aa3673104.5 (16.1)ag1038104.7 (17.0)gg74108.0 (14.3)mean difference in child iq per gallelea(95% ci)47850.55 (−0.44, 1.54)p-value0.28\nAllele mentioned has been ASSOCIATED with higher Vitamin B-12 or lower Hcy levels.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('SUPERFICIAL_RELATIONSHIP', 265), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 864)]	4	[('SO_0000694', 'SNP', 301, 'SNPs'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 317, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 317, 'vitamin B-12'), ('SO_0001627', 'intron_variant', 368, 'SNPgenotypeNIQ'), ('PR_000007719', 'frizzled-2', 393, 'FUT2'), ('SO_0001023', 'allele', 838, 'Allele'), ('CHEBI_70326', 'guttiferone A, (rel-(+))-', 887, 'vitamin B-'), ('PR_000017269', 'ventral anterior homeobox 2', 887, 'vitamin B-12'), ('PR_000008443', 'huntingtin-associated protein 1', 909, 'Hcy')]
S135-PMC3515553	PMC3515553	12/2012	S135-PMC3515553	['FINDINGS in the context of existing literature\ntcn2 rs1801198 was ASSOCIATED with maternal Vitamin B-12 Consumption, with heterozygotes showing a higher intake than both homozygotes, ALTHOUGH this COULD WELL be a chance FINDING SINCE this Snp’s PUTATIVE action has not been RELATED to Intake[13].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 220), ('PROBLEM_COMPLICATION', 228), ('PROBABLE_UNDERSTANDING', 245), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 104, 'consumption'), ('SO_0000694', 'SNP', 239, 'SNP'), ('GO_0007631', 'feeding behavior', 285, 'intake')]
S164-PMC3515553	PMC3515553	12/2012	S164-PMC3515553	['additionally, the Snps that we have used HERE as PROXIES for the unconfounded ASSOCIATION of maternal Vitamin B-12 with offspring iq explain ONLY a small proportion of the variance of Plasma Vitamin B-12[11],[39].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 141)]	4	[('SO_0000694', 'SNP', 18, 'SNPs'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 102, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 112, '12'), ('UBERON_0001969', 'blood plasma', 184, 'plasma'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 191, 'vitamin B-12')]
S167-PMC3515553	PMC3515553	12/2012	S167-PMC3515553	['because we used smaller subsets of samples from the original alspac study to assess ASSOCIATIONS of Snps with Cord Blood Vitamin B-12 and iq, there is always the POSSIBILITY of these subsets not being representative of the population under study.']	[('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 162)]	2	[('SO_0000694', 'SNP', 100, 'SNPs'), ('UBERON_0009472', 'axilla', 110, 'cord blood'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 121, 'vitamin B-12')]
S177-PMC3515553	PMC3515553	12/2012	S177-PMC3515553	['caption (supplementary-material): table s3\n\nASSOCIATION of offspring genotype at Snps RELATED to Vitamin B-12 Metabolism with Vitamin B-12 Cord Blood concentration.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('SO_0000694', 'SNP', 81, 'SNPs'), ('CHEBI_70326', 'guttiferone A, (rel-(+))-', 97, 'vitamin B-'), ('GO_0000010', 'trans-hexaprenyltranstransferase activity', 97, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 97, 'vitamin B-12'), ('GO_0008152', 'metabolic process', 110, 'metabolism'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 126, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 139, 'cord'), ('UBERON_0000178', 'blood', 144, 'blood')]
S181-PMC3515553	PMC3515553	12/2012	S181-PMC3515553	['caption (supplementary-material): table s5\n\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with offspring iq at age 8, stratified by Maternal Pregnancy RECOMMENDED daily amount (rda) of Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 85), ('FUTURE_WORK', 181)]	3	[('SO_0000694', 'SNP', 80, 'SNPs'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 96, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 96, 'vitamin B-12'), ('GO_0007618', 'mating', 162, 'maternal'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 215, 'vitamin B-12')]
S227-PMC3613945	PMC3613945	2/2013	S227-PMC3613945	['explored PREVIOUS epidemiological EVIDENCE SUGGESTING a reduced risk ASSOCIATED with Vitamin D. NO EVIDENCE for ASSOCIATION between dbp genotype and risk of Colorectal cancer was FOUND, ALTHOUGH ASSOCIATIONS between dbp Snps and microsatellite-unstable Colorectal cancer were REPORTED168.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 276)]	10	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0012652', 'colorectum', 157, 'colorectal'), ('SO_0000694', 'SNP', 220, 'SNPs'), ('UBERON_0012652', 'colorectum', 253, 'colorectal')]
S243-PMC3613945	PMC3613945	2/2013	S243-PMC3613945	['ongoing interventional trials with Vitamin D and ASSOCIATION studies with larger cohorts MAY offer FURTHER OPPORTUNITY to explore an INTERACTIVE ROLE of dbp Snps with Vitamin D in ms.\n\namyotrophic lateral sclerosis\namyotrophic lateral sclerosis (als) is another neuropathy of UNKNOWN etiology that is characterized by the progressive loss of Motor Neurons in the Brain and spinal Cord, leading to debilitating, USUALLY fatal, muscle atrophy180.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 145), ('FULL_UNKNOWN', 276), ('INCOMPLETE_EVIDENCE', 411)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000694', 'SNP', 157, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CL_0000100', 'motor neuron', 342, 'motor neurons'), ('UBERON_0000955', 'brain', 363, 'brain'), ('UBERON_0002240', 'spinal cord', 380, 'cord')]
S75-PMC3695234	PMC3695234	7/2013	S75-PMC3695234	['BASED ON the identification of Vitamin D receptors in RELEVANT Immune Cells, it HAS BEEN SUGGESTED that the Vitamin D pathway plays a ROLE in asthma and atopy.19,20using Single Nucleotide Polymorphism selection and genotyping, poon et al.20found six variants that are strongly ASSOCIATED with asthma and four with atopy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000694', 'SNP', 170, 'single nucleotide polymorphism')]
S86-PMC3773018	PMC3773018	4/2013	S86-PMC3773018	['it SHOULD BE NOTED that four Snps SHOWED significant INTERACTION EFFECTS with Vitamin D deficiency at Birth on fs in our PREVIOUS report (18).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 121)]	6	[('SO_0000694', 'SNP', 29, 'SNPs'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'birth')]
S101-PMC4113768	PMC4113768	7/2014	S101-PMC4113768	['Cyp2R1 and Cyp24A1 are capable of the 25-hydroxylation and 24-Hydroxylation, respectively, of Vitamin D. IT IS REPORTED that different Single Nucleotide Polymorphisms of Cyp2R1 and Cyp24A1 are ASSOCIATED with the 25(Oh)D status (wang, t.j., et al.']	[('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 11, 'CYP24A1'), ('GO_0006298', 'mismatch repair', 59, '24-hydroxylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000694', 'SNP', 135, 'single nucleotide polymorphisms'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 170, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 181, 'CYP24A1'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D')]
S962-PMC4113768	PMC4113768	7/2014	S962-PMC4113768	['thirty-seven Single Nucleotide Polymorphisms (Snps) in 13 Genes (dbp, Dhcr7, Cubn, Lrp2, Crtam, Lta4H, Cyp2R1, Cyp3A4, Cyp27A1, Cyp27B1, Cyp24A1, vdr, rxra), INVOLVED with Vitamin D Transport, Metabolism and Signalling were typed using taqman Allelic discrimination assays.']	[('SUPERFICIAL_RELATIONSHIP', 158)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 58, 'genes'), ('PR_000006474', 'ATP-dependent RNA helicase A', 70, 'DHCR7'), ('PR_000006022', 'lysosomal protective protein', 77, 'CUBN'), ('PR_000009920', 'low-density lipoprotein receptor-related protein 1B', 83, 'LRP2'), ('PR_000005866', 'cAMP-responsive element modulator', 89, 'CRTAM'), ('PR_000009920', 'low-density lipoprotein receptor-related protein 1B', 96, 'LTA4H'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 103, 'CYP2R1'), ('PR_000006131', 'cytochrome P450 3A43', 111, 'CYP3A4'), ('PR_000006101', 'cytochrome P450 1A1', 119, 'CYP27A1'), ('PR_000006101', 'cytochrome P450 1A1', 128, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 137, 'CYP24A1'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0007601', 'visual perception', 172, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 182, 'transport ...'), ('GO_0009554', 'megasporogenesis', 193, 'metabolism ... signalling'), ('SO_0001023', 'allele', 243, 'allelic')]
S1415-PMC4113768	PMC4113768	7/2014	S1415-PMC4113768	['conclusions: the vdr Snp rs7968585 PREDICTS the occurrence of t2dm, which MAY INDICATE a ROLE of Vitamin D in the pathogenesis of t2dm.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('SO_0000694', 'SNP', 21, 'SNP'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S1522-PMC4113768	PMC4113768	7/2014	S1522-PMC4113768	['the participants were genotyped for 25 Snps in the Vitamin D pathway and two common Single Nucleotide Polymorphisms (Snps) in the Cyp2R1 Gene (rs10741657 and rs10766197) and two common Snps in the gc Gene (rs4588 and rs842999) were FOUND to PREDICT baseline S-25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 241)]	2	[('SO_0000694', 'SNP', 39, 'SNPs'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007601', 'visual perception', 51, 'vitamin D'), ('SO_0000694', 'SNP', 84, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 117, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 130, 'CYP2R1'), ('SO_0000704', 'gene', 137, 'gene'), ('SO_0000694', 'SNP', 185, 'SNPs'), ('SO_0000704', 'gene', 200, 'gene'), ('PR_000015800', 'syntaxin-8', 258, 's-25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 260, '25(OH)D')]
S2566-PMC4113768	PMC4113768	7/2014	S2566-PMC4113768	['eighty-eight Single Nucleotide Polymorphisms (Snps) in 41 candidate Genes RELATED to Vitamin D status were genotyped using sequenom massarray technology.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 68, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S3097-PMC4113768	PMC4113768	7/2014	S3097-PMC4113768	['THE CURRENT STUDY was DESIGNED TO IDENTIFY the EFFECT of Vitamin D insufficiency and deficiency (vdid) and host Genetic Single Nucleotide Polymorphisms (Snps) that alter Vitamin d receptor Expression on the RISK for tb in hiv-infected and –exposed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 207)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('SO_0000704', 'gene', 112, 'genetic'), ('SO_0000694', 'SNP', 120, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 153, 'SNPs'), ('CHEBI_33229', 'vitamin (role)', 170, 'Vitamin'), ('GO_0010467', 'gene expression', 189, 'expression')]
S160-PMC4377870	PMC4377870	3/2015	S160-PMC4377870	['in an OBSERVATIONAL study Single Nucleotide Polymorphisms in the Vitamin D Binding Protein (Vdbp) PREDICTED Vitamin D levels in copd patients and were FOUND TO BE a risk FACTOR for copd [123].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('SO_0000694', 'SNP', 26, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 65, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 92, 'VDBP'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
S132-PMC5155676	PMC5155676	12/2016	S132-PMC5155676	['it HAS BEEN demonstrated PREVIOUSLY that the incremental rise in 25(Oh)D after supplementation DIFFERS by Single Nucleotide Polymorphisms in Vitamin D Binding Protein (33,34) and 25-hydroxylase Genes (33).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	3	[('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 65, '25(OH ... D'), ('SO_0000694', 'SNP', 106, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 141, 'vitamin D binding protein'), ('SO_0000704', 'gene', 194, 'genes')]
S60-PMC5372327	PMC5372327	3/2017	S60-PMC5372327	['these included Single Nucleotide Polymorphisms in the gc Gene encoding Vitamin D Binding Protein, locus near the 7-Dehydrocholesterol reductase INVOLVED in Vitamin D Synthesis in the skin, and Cyp2R1 coding Cytochrome P450 responsible for 25-Hydroxylation.']	[('SUPERFICIAL_RELATIONSHIP', 144)]	1	[('SO_0000694', 'SNP', 15, 'single nucleotide polymorphisms'), ('SO_0000704', 'gene', 57, 'gene'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 71, 'vitamin D binding protein'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 113, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 156, 'vitamin D synthesis'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 193, 'CYP2R1'), ('CHEBI_38557', 'cytochrome c2', 207, 'cytochrome P450'), ('PR_000006100', 'aromatase', 207, 'cytochrome P450'), ('CHEBI_52846', 'cycloalkane ring', 239, '25-hydroxylation')]
S0-PMC5546866	PMC5546866	8/2017	S0-PMC5546866	['response to antenatal Cholecalciferol supplementation is ASSOCIATED with common Vitamin D–related Genetic variants\n\nabstract\n\ncontext:\nSingle-Nucleotide Polymorphisms (Snps) in Genes RELATED to Vitamin D Metabolism HAVE BEEN ASSOCIATED with Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, BUT these RELATIONSHIPS have NOT BEEN EXAMINED following Antenatal Cholecalciferol supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 183), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('SUPERFICIAL_RELATIONSHIP', 302), ('FULL_UNKNOWN', 321)]	7	[('CHEBI_16113', 'cholesterol', 22, 'Cholecalciferol'), ('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 80, 'Vitamin D'), ('SO_0000704', 'gene', 98, 'Genetic'), ('SO_0000694', 'SNP', 135, 'Single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 168, 'SNPs'), ('SO_0000704', 'gene', 177, 'genes'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 202, 'D metabolism'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 247, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('GO_0007567', 'parturition', 349, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 359, 'cholecalciferol')]
S11-PMC5546866	PMC5546866	8/2017	S11-PMC5546866	['conclusions:\nGenetic variation in Dhcr7 , which encodes 7-Dehyrocholesterol reductase in the Epidermal Vitamin D Biosynthesis pathway, APPEARS to modify baseline 25(Oh)D. IN CONTRAST, the response to Antenatal Cholecalciferol supplementation was ASSOCIATED with Snps in Cyp2R1 , which MAY alter 25-hydroxylase activity, and gc , which MAY AFFECT Vitamin D binding Protein Synthesis or Metabolite affinity.']	[('ANOMALY_CURIOUS_FINDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171), ('SUPERFICIAL_RELATIONSHIP', 246), ('INCOMPLETE_EVIDENCE', 285), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 339)]	6	[('SO_0000704', 'gene', 13, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 34, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 56, '7-dehyrocholesterol'), ('UBERON_0007376', 'outer epithelium', 93, 'epidermal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 103, 'vitamin D biosynthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 210, 'cholecalciferol'), ('SO_0000694', 'SNP', 262, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 270, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('GO_0006412', 'translation', 364, 'protein synthesis'), ('CHEBI_39382', 'flufenoxuron', 385, 'metabolite')]
S12-PMC5546866	PMC5546866	8/2017	S12-PMC5546866	['abstract:teaser\nASSOCIATIONS between Snps in the Vitamin D Metabolism pathway and 25(Oh)D were ASSESSED before and after Antenatal Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	2	[('SO_0000694', 'SNP', 37, 'SNPs'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 49, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 57, 'D'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('GO_0007567', 'parturition', 121, 'antenatal'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
S19-PMC5546866	PMC5546866	8/2017	S19-PMC5546866	['in a PREVIOUS Genome-wide association study (gwas), we DEMONSTRATED that a NUMBER OF Single-Nucleotide Polymorphisms (Snps) in or near to Genes encoding KEY components of the Vitamin D Metabolism pathway are ASSOCIATED with Serum 25(Oh)D level (8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('SO_0001026', 'genome', 14, 'genome'), ('SO_0000694', 'SNP', 85, 'single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 118, 'SNPs'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 175, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 224, 'serum'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 233, 'OH ... D')]
S21-PMC5546866	PMC5546866	8/2017	S21-PMC5546866	['several of these Snps have been ASSOCIATED with the Serum 25(Oh)D increase in response to Vitamin D supplementation in SMALL STUDIES (9–11).']	[('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 119)]	2	[('SO_0000694', 'SNP', 17, 'SNPs'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
S27-PMC5546866	PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
S129-PMC5546866	PMC5546866	8/2017	S129-PMC5546866	['the Dhcr7 Gene encodes 7-Dhc reductase, which converts 7-Dhc back to Cholesterol, thereby reducing the availability of 7-Dhc for conversion to previtamin d. the ASSOCIATION of this Snp with only baseline 25(Oh)D is biologically CONSISTENT with the NOTION that the relative proportion of 25(Oh)D obtained from Vitamin D Biosynthesis in the skin AS OPPOSED TO dietary intake is lower following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 161), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344)]	4	[('PR_000006474', 'ATP-dependent RNA helicase A', 4, 'DHCR7'), ('SO_0000704', 'gene', 10, 'gene'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 23, '7-DHC'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 55, '7-DHC'), ('CHEBI_16113', 'cholesterol', 69, 'cholesterol'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 119, '7-DHC'), ('SO_0000694', 'SNP', 181, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 204, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 287, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 293, 'D'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 309, 'vitamin D biosynthesis')]
S132-PMC5546866	PMC5546866	8/2017	S132-PMC5546866	['we FOUND that the rs10741657 Snp was not associated with baseline 25(Oh)D BUT was ASSOCIATED with the response to Gestational Vitamin D supplementation, THEREFORE SUGGESTING that this Snp ONLY modifies 25(Oh)D status when the substrate is more readily available and that at the baseline measurement, saturation of the enzyme had not been reached.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBABLE_UNDERSTANDING', 153), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 188)]	6	[('SO_0000694', 'SNP', 29, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 66, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('SO_0000694', 'SNP', 184, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D')]
S151-PMC5546866	PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
